BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND GNAQ, P50148, 2776, ENSG00000156052, G-ALPHA-q, RP11-494N1_1, GAQ
88551 results:

  • 1. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
    Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
    Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
    Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
    Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor derived exosomal ENTPD2 impair CD8
    Shi M; Ye L; Zhao L; He L; Chen J; Zhang J; Su Y; Dong H; Liu J; Liang L; Zheng W; Xiao Y; Liu H; Yang X; Yang Z
    Cell Commun Signal; 2024 May; 22(1):274. PubMed ID: 38755598
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.
    Altves S; Guclu E; Yetisgin E; Bilecen K; Vural H
    World J Microbiol Biotechnol; 2024 May; 40(7):204. PubMed ID: 38755413
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
    Gargett T; Truong NTH; Gardam B; Yu W; Ebert LM; Johnson A; Yeo ECF; Wittwer NL; Tapia Rico G; Logan J; Sivaloganathan P; Collis M; Ruszkiewicz A; Brown MP
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754916
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. When to reinvite initially ineligible populations for targeted lung cancer screening?
    Goodley P; Crosbie PAJ; Sperrin M; Merchant Z; Booton R; Balata H
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754907
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Determinants and Factors of Physical Activity After Oncology Treatments (DEFACTO) in Metropolitan France: Protocol of a Mixed Methods Study and Intervention.
    Aumaitre A; Gagnayre R; Foucaut AM
    JMIR Res Protoc; 2024 May; 13():e52274. PubMed ID: 38753415
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in cancer: A Systematic Review and Meta-Analysis.
    Gao L; Fan J; He J; Che X; Wang X; Han C
    Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CircAGFG1 Promotes Ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Understanding the interplay of colorectal cancer awareness and attitudes among Palestinians: a national cross-sectional study.
    Elshami M; Dwikat MF; Al-Slaibi I; Alser M; Albandak ME; Ayyad M; Naji SA; Mohamad BM; Isleem WS; Shurrab A; Yaghi B; Qabaja YA; Hamdan FK; Sweity RR; Jneed RT; Assaf KA; Hmaid MM; Awwad II; Alhabil BK; Alarda MN; Alsattari AS; Aboyousef MS; Aljbour OA; AlSharif R; Giacaman CT; Alnaga AY; Nemer RMA; Almadhoun NM; Skaik SM; Albarqi SI; Abu-El-Noor N; Bottcher B
    BMC Cancer; 2024 May; 24(1):590. PubMed ID: 38750448
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effect of GP visits in the compliance of preventive services: a cross-sectional study in Europe.
    Ares-Blanco S; López-Rodríguez JA; Polentinos-Castro E; Del Cura-González I
    BMC Prim Care; 2024 May; 25(1):165. PubMed ID: 38750446
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
    Stany B; Mishra S; Rao KVB
    Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials.
    Segal NH; Melero I; Moreno V; Steeghs N; Marabelle A; Rohrberg K; Rodriguez-Ruiz ME; Eder JP; Eng C; Manji GA; Waterkamp D; Leutgeb B; Bouseida S; Flinn N; Das Thakur M; Elze MC; Koeppen H; Jamois C; Martin-Facklam M; Lieu CH; Calvo E; Paz-Ares L; Tabernero J; Argilés G
    Nat Commun; 2024 May; 15(1):4091. PubMed ID: 38750034
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The double burden of severe mental illness and cancer: a population-based study on colorectal cancer care pathways from screening to end-of-life care.
    Seppänen AV; Daniel F; Houzard S; Le Bihan C; Coldefy M; Gandré C
    Epidemiol Psychiatr Sci; 2024 May; 33():e27. PubMed ID: 38747198
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of ROS and KEAP1-related genes and verified targets of α-hederin induce cell death for CRC.
    Wang G; Zhu ZM; Wang K
    Drug Dev Res; 2024 May; 85(3):e22200. PubMed ID: 38747107
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy.
    Liang Y; Luo H; Li X; Liu S; Habib A; Liu B; Huang J; Wang J; Yi H; Hu B; Zheng L; Xie J; Zhu N
    Front Immunol; 2024; 15():1367040. PubMed ID: 38745661
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
    Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
    BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Effectiveness of 23-valent Pneumococcal Polysaccharide Vaccine on Elderly colorectal cancer Long-Term Survivors: A population-based exact-matched cohort study.
    Lee MS; Chiou SY; Hsu FC; Lin HY; Li CY; Hung SK; Yu BH; Wu CC; Chen LC; Chew CH; Chiou WY
    Hum Vaccin Immunother; 2024 Dec; 20(1):2350093. PubMed ID: 38744302
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quality of Life in Patients Undergoing Emergency Surgery for Complex colorectal cancer: Protocol and Piloting of the Surgical Utilization and Recovery Patterns for Advanced Stage colorectal cancer Study.
    Ciubotaru C; Poenaru RC; Beuran M; Pătraşcu T; Turculeţ CȘ; Constantinescu G; Hostiuc S; Moldoveanu A; Negoi I
    Chirurgia (Bucur); 2024 Apr; 119(2):156-170. PubMed ID: 38743829
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4428.